Heart failure with mid-range ejection fraction and the effect of β-blockers after acute myocardial infarction

In conclusion, clinical profiles and prognosis of patients with post-AMI HFmrEF are largely intermediate between HFrEF and HFpEF. β-blockers reduced or tended to reduce 2-year all-cause mortality in patients with HFrEF or HFmrEF, respectively, but not those with HFpEF after AMI.
Source: Heart and Vessels - Category: Cardiology Source Type: research